CREG1 Polyclonal Antibody

The adenovirus E1A protein both activates and represses gene expression to promote cellular proliferation and inhibit differentiation. The protein encoded by this gene antagonizes transcriptional activation and cellular transformation by E1A. This protein shares limited sequence similarity with E1A and binds both the general transcription factor TBP and the tumor suppressor pRb in vitro. This gene may contribute to the transcriptional control of cell growth and differentiation.

The CREG1 Polyclonal Antibody is a highly specific and sensitive immunological reagent designed for the detection and quantification of CREG1 protein in various biological samples. This antibody is produced by immunizing rabbits with a synthetic peptide corresponding to the C-terminal region of human CREG1 protein. The resulting polyclonal antibody exhibits high affinity and specificity towards CREG1 protein, making it an ideal tool for various applications such as Western blotting, immunohistochemistry, and ELISA.

The CREG1 Polyclonal Antibody is validated for use in human, mouse, and rat samples, and has been extensively tested for its specificity and sensitivity. It has been shown to detect endogenous CREG1 protein in various tissues and cell lines, and can be used to monitor changes in CREG1 expression levels under different physiological and pathological conditions.

This antibody is supplied as a purified IgG fraction, and is suitable for use in both research and diagnostic applications. It is recommended to use this antibody at a dilution of 1:1000 for Western blotting, 1:200 for immunohistochemistry, and 1:5000 for ELISA. The CREG1 Polyclonal Antibody is a reliable and high-quality reagent that can help researchers and clinicians better understand the role of CREG1 protein in various biological processes and diseases.